Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 03, 2023, titled "Press Release regarding grant of USFDA approval for Rocuronium Bromide Injection to our Subsidiary Caplin Steriles Limited. ".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 03, 2023, titled "Press Release regarding grant of USFDA approval for Rocuronium Bromide Injection to our Subsidiary Caplin Steriles Limited. ".